Major depressive disorder. Major depressive disorder, recurrent severe without psychotic features
Conditions
Interventions
Intervention 1: Control group: control group with 30 patients that received special serotonin reuptake inhibitors ( fluvoxine20-80 mg or citalopram 20-40, or sertraline with congestion 50-200 mg ) in
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Days to 65 Days
Inclusion criteria
Inclusion criteria: Patient with major depressive disorder who had been to the psychiatric clinic of Golestan. Age witbeen 18-65 years
Exclusion criteria
Exclusion criteria: Bipolar disorder and other psychiatric disorders Drug or alcohol consumption during the research, dependence or history of drug or alcohol in 6 recent months, History of allergy to serotonin reuptake inhibitors or omega- 3fatty acids History of seizure Pregnancy Active suicidal thoughts and homicide Use of anticoagulants and medications that interfere with omega- 3 intake (such as anti-platelet drugs such as aspirin and enoxaparin and heparin and warfarin) chronic physical disease ( blood pressure, diabetes, heart disease, liver and kidney disease )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression values in beck test. Timepoint: From the start of treatment and week 2,4,6,8. Method of measurement: Beck test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dose of SSRI. Timepoint: At the beginning of treatment and week 2,4,6,8 after tratment started. Method of measurement: Evaluation of drug used based of patient file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaasome nazari nasab
Ahvaz University of Medical Sciences
Outcome results
None listed